Expression, purification, and projection structure by single particle electron microscopy of functional human TRPM4 heterologously expressed in Xenopus laevis oocytes

Protein Expression and Purification
Benjamin ClémençonMatthias A Hediger

Abstract

Despite efforts implicating the cationic channel transient receptor potential melastatin member 4 (TRPM4) to cardiac, nervous, and immunological pathologies, little is known about its structure and function. In this study, we optimized the requirements for purification and extraction of functional human TRPM4 protein and investigated its supra-molecular assembly. We selected the Xenopus laevis oocyte expression system because it lacks endogenous TRPM4 expression, it is known to overexpress functional human membrane channels, can be used for structure-function analysis within the same system, and is easily scaled to improve yield and develop moderate throughput capabilities through the use of robotics. Negative-stain electron microscopy (EM) revealed various sized low-resolution particles. Single particle analysis identified the majority of the projections represented the monomeric form with additional oligomeric structures potentially characterized as tetramers. Two-electrode voltage clamp electrophysiology demonstrated that human TRPM4 is functionally expressed at the oocyte plasma membrane. This study opens the door for medium-throughput screening and structure-function determination of this important therapeutically relevant...Continue Reading

References

Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·X Z XuC Montell
Nov 7, 2003·Nature·Eva Pebay-PeyroulaGérard Brandolin
Dec 4, 2003·Acta Crystallographica. Section D, Biological Crystallography·Cécile Dahout-GonzalezEva Pebay-Peyroula
Apr 23, 2005·The Journal of Biological Chemistry·Bernd NiliusThomas Voets
Jun 30, 2006·Cell Calcium·Henrique ChengReinhold Penner
Jul 25, 2006·Journal of Structural Biology·Guang TangSteven J Ludtke
Jan 30, 2007·Journal of Molecular Biology·Kazuhiro MioChikara Sato
May 10, 2007·Nature Protocols·Mireille ChevalletThierry Rabilloud
May 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Vera Y Moiseenkova-BellTheodore G Wensel
Sep 11, 2008·Journal of Molecular Biology·Yuichiro Fujiwara, Daniel L Minor
Sep 4, 2009·The Journal of Clinical Investigation·Martin KruseOlaf Pongs
Jan 2, 2010·The Journal of Biological Chemistry·Hideki ShigematsuKuniaki Nagayama
Jun 22, 2010·Circulation. Cardiovascular Genetics·Hui LiuPatrice Bouvagnet
Jul 4, 2012·Biochemical Pharmacology·Hugues AbrielJean-Sébastien Rougier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.